Total Payments
$20,425
2024 Payments
$1,905
Companies
74
Transactions
1,543
Medicare Patients
8,844
Medicare Billing
$668,145
Payment Breakdown by Category
Food & Beverage$20,191 (98.9%)
Education$234.27 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,191 | 1,516 | 98.9% |
| Education | $234.27 | 27 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,054 | 177 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,462 | 88 | $0 (2024) |
| Amgen Inc. | $1,406 | 98 | $0 (2024) |
| PFIZER INC. | $1,210 | 90 | $0 (2024) |
| ABBVIE INC. | $1,131 | 102 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $841.59 | 99 | $0 (2022) |
| GlaxoSmithKline, LLC. | $835.54 | 71 | $0 (2023) |
| Lilly USA, LLC | $818.16 | 57 | $0 (2024) |
| Optinose US, Inc. | $776.52 | 53 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $744.31 | 46 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,905 | 120 | PFIZER INC. ($303.82) |
| 2023 | $2,497 | 166 | GlaxoSmithKline, LLC. ($285.54) |
| 2022 | $2,676 | 182 | ABBVIE INC. ($337.78) |
| 2021 | $3,141 | 245 | AbbVie Inc. ($322.50) |
| 2020 | $2,280 | 174 | Allergan, Inc. ($313.54) |
| 2019 | $2,321 | 196 | AstraZeneca Pharmaceuticals LP ($247.87) |
| 2018 | $2,586 | 211 | Novo Nordisk Inc ($354.80) |
| 2017 | $3,019 | 249 | Novo Nordisk Inc ($316.23) |
All Payment Transactions
1,543 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Oncology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Insomnia | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: VACCINES | ||||||
| 10/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.89 | General |
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Insomnia | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: VACCINES | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Bone Health | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Insomnia | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,142 | 4,602 | $252,825 | $134,296 |
| 2022 | 36 | 2,064 | 6,303 | $290,565 | $166,736 |
| 2021 | 40 | 2,234 | 7,251 | $335,788 | $193,038 |
| 2020 | 41 | 2,404 | 7,360 | $349,199 | $174,076 |
Total Patients
8,844
Total Services
25,516
Medicare Billing
$668,145
Procedure Codes
155
All Medicare Procedures & Services
155 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 236 | 465 | $75,335 | $35,341 | 46.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 186 | 276 | $60,948 | $30,627 | 50.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 219 | 219 | $38,325 | $26,543 | 69.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 319 | 644 | $6,220 | $5,191 | 83.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 37 | 73 | $11,038 | $4,352 | 39.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 56 | $4,480 | $3,953 | 88.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $3,960 | $3,375 | 85.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 27 | 62 | $6,390 | $2,193 | 34.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,055 | $2,025 | 66.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 72 | 201 | $6,030 | $1,825 | 30.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 61 | $1,952 | $1,710 | 87.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 100 | 124 | $1,860 | $1,592 | 85.6% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 96 | 98 | $2,160 | $1,529 | 70.8% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 33 | 43 | $2,580 | $1,300 | 50.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 47 | 62 | $2,542 | $1,290 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $3,220 | $1,199 | 37.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 25 | 28 | $1,400 | $1,135 | 81.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 27 | 27 | $2,214 | $932.31 | 42.1% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 21 | 22 | $2,860 | $857.60 | 30.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 75 | 1,066 | $1,812 | $808.13 | 44.6% |
| 70210 | X-ray of paranasal sinus, 1-2 views | Office | 2023 | 28 | 36 | $1,440 | $740.05 | 51.4% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 16 | 20 | $1,720 | $728.17 | 42.3% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 23 | 27 | $2,619 | $676.40 | 25.8% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 23 | 23 | $1,495 | $662.27 | 44.3% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 17 | 22 | $1,628 | $607.60 | 37.3% |
About Dr. Jeffery Laubenthal, MD
Dr. Jeffery Laubenthal, MD is a Family Medicine healthcare provider based in Tuscaloosa, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184796211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffery Laubenthal, MD has received a total of $20,425 in payments from pharmaceutical and medical device companies, with $1,905 received in 2024. These payments were reported across 1,543 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($20,191).
As a Medicare-enrolled provider, Laubenthal has provided services to 8,844 Medicare beneficiaries, totaling 25,516 services with total Medicare billing of $668,145. Data is available for 4 years (2020–2023), covering 155 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Tuscaloosa, AL
- Active Since 11/14/2006
- Last Updated 02/21/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1184796211
Products in Payments
- Ozempic (Drug) $906.21
- Xhance (Drug) $776.52
- FARXIGA (Drug) $762.46
- TRELEGY ELLIPTA (Drug) $656.63
- XARELTO (Drug) $641.10
- VRAYLAR (Drug) $637.22
- Vascepa (Drug) $533.89
- UBRELVY (Drug) $487.83
- NURTEC ODT (Drug) $474.43
- TRINTELLIX (Drug) $430.35
- Otezla (Drug) $399.51
- Kerendia (Drug) $387.39
- MOUNJARO (Drug) $363.78
- Prolia (Biological) $353.15
- EVENITY (Biological) $326.24
- JANUVIA (Drug) $297.60
- Victoza (Drug) $296.04
- Dayvigo (Drug) $283.48
- TRULICITY (Drug) $279.22
- Saxenda (Drug) $276.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tuscaloosa
Kelly Hunter, M.d, M.D
Family Medicine — Payments: $54,314
Family Medicine $54,314
Dr. Craig Buettner, Md, MD
Family Medicine — Payments: $20,694
Family Medicine $20,694
Katherine Grelle, Md, MD
Family Medicine — Payments: $11,665
Family Medicine $11,665
Remona Peterson, Md, MD
Family Medicine — Payments: $8,135
Family Medicine $8,135
William Taunton, M.d, M.D
Family Medicine — Payments: $7,886
Family Medicine $7,886
Dr. Jennifer Burdette, M.d, M.D
Family Medicine — Payments: $7,603
Family Medicine $7,603